See also this year's filing and all EDGAR filings for this company.
PDF Report 0001596062_2023_Q_BioMed_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 2.6809888666575335e-07, 'aggregate_val': 3729968, 'exp_sum': 3729967, 'exp_to_value': {'CostOfGoodsAndServicesSold': 293340, 'SellingGeneralAndAdministrativeExpense': 3311249, 'ResearchAndDevelopmentExpense': 125378, 'remainder_Expenses': 0}} |
Graph
Absolute values for 0001596062, Q BioMed Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 72,316 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 300,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,143,201 |
| 4 | LiabilitiesCurrent | 8,132,940 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 293,340 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,311,249 |
| 9 | ResearchAndDevelopmentExpense | 125,378 |
| 10 | remainder_Expenses | 1.00 |
| 11 | remainder_Revenues | 284,352 |
| 12 | remainder_NetIncome | 1,393,523 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,515,517 |
| 1 | Liabilities | 8,132,940 |
| 2 | Expenses | 3,729,968 |
| 3 | Revenues | 284,352 |
| 4 | StockholdersEquity | -4,617,423 |
| 5 | NetIncome | -2,052,093 |
| 6 | ComprehensiveNetIncome | -2,052,093 |
| 7 | BaseVar | 8,528,150 |
| 8 | EconomicCapitalRatio | -1.72 |
Edgar->Model Mapping
Feature Distribution
Change over Time
